23rd February 2022 | Pharma Updates

The Global Healthcare Trust Barometer has India at the top of the list

On the trust barometer, the Indian pharmaceutical sector performed very well. It has once again topped the charts in 28 nations.

Antibiotics benefit from Omicron. Azithral outsold the best-selling anti-diabetic medication

Omicron effect is what it’s called. Azithral surpassed Human Mixtard, the market leader in anti-diabetic therapy, to become the largest-selling pharma brand for the first time.

In tribal districts, 66 doctors were hired on a contract basis.

Chhattisgarh government has appointed 66 MBBS students to contract positions as physicians.

CEPI, THSTI, and Panacea Biotec will collaborate to create Beta-coronavirus vaccines.

CEPI will collaborate with the Translational Health Science and Technology Institute (THSTI) and Panacea Biotec to create vaccine candidates that potentially give wide protection against SARS-COV-2 variants and other Beta-Coronaviruses.

With the completion of a breast cancer trial, AstraZeneca strengthens its oncology credentials.

As per AstraZeneca, Enhertu extended life and delayed the spread of metastatic breast cancer with low levels of HER2.

Binnopharm will purchase two antibacterial products from Dr. Reddy's.

Binnopharm will buy Dr Reddy’s Laboratories’ anti-bacterial drugs sold under the Ciprolet and Levolet brands in Russia, Uzbekistan, and Belarus.

According to a UN assessment, baby formula marketing is "pervasive, deceptive, and aggressive. "

WHO Director-General Margaret Chan, urging for laws on exploitative marketing to be “urgently enacted and enforced to protect children’s health. “

Moderna began late-stage research on an RSV vaccine utilising mRNA technology.

The sole authorised medication based on messenger RNA (mRNA) is the COVID-19 vaccine, but Moderna and competitor Pfizer are racing to capitalise on the technology’s potential to treat illnesses such as shingles and cancer.

WHO states thatthe Omicron variation is no more severe than the original strain.

According to the World Health Organization, the BA.2 version of the Omicron coronavirus strain is no more dangerous than the original.

WHO predicts that the covid epidemic will stop in 2022.

If there are no further large Covid outbreaks after Omicron, the pandemic might be over by 2022, according to the World Health Organization (WHO) Representative in Russia.